Mechanism of action of mRNA-based vaccines
- PMID: 28701102
- DOI: 10.1080/14760584.2017.1355245
Mechanism of action of mRNA-based vaccines
Abstract
The present review summarizes the growing body of work defining the mechanisms of action of this exciting new vaccine technology that should allow rational approaches in the design of next generation mRNA vaccines. Areas covered: Bio-distribution of mRNA, localization of antigen production, role of the innate immunity, priming of the adaptive immune response, route of administration and effects of mRNA delivery systems. Expert commentary: In the last few years, the development of RNA vaccines had a fast growth, the rising number of proof will enable rational approaches to improving the effectiveness and safety of this modern class of medicine.
Keywords: Intrinsic adjuvanticity; antiviral response; delivery system; innate immunity; optimization; self-amplifying mRNA (SAM); type I interferon.
Similar articles
-
Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines.Expert Opin Drug Deliv. 2014 Jun;11(6):885-99. doi: 10.1517/17425247.2014.901308. Epub 2014 Mar 26. Expert Opin Drug Deliv. 2014. PMID: 24665982 Review.
-
Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity.Vaccine. 2016 Jul 19;34(33):3882-93. doi: 10.1016/j.vaccine.2016.05.046. Epub 2016 Jun 18. Vaccine. 2016. PMID: 27269061
-
Challenges and advances towards the rational design of mRNA vaccines.Trends Mol Med. 2013 Dec;19(12):705-13. doi: 10.1016/j.molmed.2013.09.002. Epub 2013 Oct 15. Trends Mol Med. 2013. PMID: 24138818 Review.
-
Messenger RNA-based vaccines: progress, challenges, applications.Wiley Interdiscip Rev RNA. 2013 Nov-Dec;4(6):737-49. doi: 10.1002/wrna.1189. Epub 2013 Jul 25. Wiley Interdiscip Rev RNA. 2013. PMID: 23893949 Review.
-
Vaccines 'on demand': science fiction or a future reality.Expert Opin Drug Discov. 2015 Feb;10(2):101-6. doi: 10.1517/17460441.2015.996128. Epub 2015 Jan 13. Expert Opin Drug Discov. 2015. PMID: 25582273
Cited by 24 articles
-
Nanocarrier Vaccines for SARS-CoV-2.Adv Drug Deliv Rev. 2021 Jan 8:S0169-409X(21)00002-8. doi: 10.1016/j.addr.2021.01.002. Online ahead of print. Adv Drug Deliv Rev. 2021. PMID: 33428995 Free PMC article.
-
Advances in gene-based vaccine platforms to address the COVID-19 pandemic.Adv Drug Deliv Rev. 2021 Jan 7;170:113-141. doi: 10.1016/j.addr.2021.01.003. Online ahead of print. Adv Drug Deliv Rev. 2021. PMID: 33422546 Free PMC article.
-
Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines.Pharmaceutics. 2020 Dec 30;13(1):45. doi: 10.3390/pharmaceutics13010045. Pharmaceutics. 2020. PMID: 33396817 Free PMC article. Review.
-
Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines.NPJ Vaccines. 2020 Sep 18;5:88. doi: 10.1038/s41541-020-00238-8. eCollection 2020. NPJ Vaccines. 2020. PMID: 33024579 Free PMC article. Review.
-
mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection.Int J Mol Sci. 2020 Sep 9;21(18):6582. doi: 10.3390/ijms21186582. Int J Mol Sci. 2020. PMID: 32916818 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
